Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized sodium nitrite and argon inhalation in healthy adults and patients with hypertension
ACTRN12622001330730Phase 2Recruiting
- Sponsor
- The University of Auckland
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of sodium nitrite in hypertension (HTN) (2 arms), sponsored by The University of Auckland. Primary endpoints: Resting brachial blood pressure and Global cerebral blood flow. Started Jan 2026; status: recruiting.
02
Drugs
sodium nitrite
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ACTRN12622001330730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001330730.